Epstein-Barr virus-dependent lymphoproliferative disease: Critical role of IL-6

European Journal of Immunology

Volumn 30, Issue 7, 2000, Pages 2065-2073

  Mauray, Sandrine ^a   Fuzzati Armentero, Marie Thérèse ^a   Trouillet, Philippe ^a   Rüegg, Marlies ^a   Nicoloso, Grazia ^b   Hart, Margreet ^c   Aarden, Lucien ^c   Schapira, Marc ^a   Duchosal, Michel A ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Blood Transfusion Center   (Switzerland)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Epstein Barr virus; IL 6; Lymphoproliferative disease; SCID mouse; Xenotransplantation

Indexed keywords

IMMUNOGLOBULIN; INTERLEUKIN 6; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CANCER INCIDENCE; CARCINOGENESIS; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PLASMA CELL; PRIORITY JOURNAL; SCID MOUSE; SURVIVAL; VIRUS REPLICATION; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES, VIRAL; BURKITT LYMPHOMA; CELL TRANSPLANTATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HERPESVIRUS 4, HUMAN; HUMANS; INCIDENCE; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LYMPHOPROLIFERATIVE DISORDERS; MICE; MICE, SCID;

EID: 0033949938     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200007)30:7<2065::AID-IMMU2065>3.0.CO;2-W     Document Type: Article

References (39)

1. Knowles, D. M., Cesarman, E., Chadburn, A., Frizzera, G., Chen, J., Rose, E. A. and Michler, R. E., Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995. 85: 552-565.
2. Mosier, D. E., Gulizia, R. J., Baird, S. M. and Wilson, D. B., Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988. 335: 256-259.
3. Rowe, M., Young, L. S., Crocker, J., Stokes, H., Henderson, S. and Rickinson, A. B., Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man. J. Exp. Med. 1991: 173: 147-158.
4. Cannon, M. J., Pisa, P., Fox, R. I. and Cooper, N. R., Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. J. Clin. Invest. 1990. 85: 1333-1337.
5. Tighe, H., Silverman, G. J., Kozin, F., Tucker, R., Gulizia, R., Peebles, C., Lotz, M., Rhodes, G., Machold, K., Mosier, D. E. and Carson, D. A., Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patients. Eur. J. Immunol. 1990. 20: 1843-1848.
6. Veronesi, A., Coppola, V., Veronese, M. L., Menin, C., Bruni, L., D'Andrea, E., Mion, M., Amadori, A. and Chieco-Bianchi, L., Lymphoproliferative disease in human peripheral-blood-mononuclear-cell-injected SCID mice. II. Role of host and donor factors in tumor generation. Int. J. Cancer 1994. 59: 676-683.
7. Akira, S., Taga, T. and Kishimoto, T., Interleukin-6 in biology and medicine. Adv. Immunol. 1993. 54: 1-78.
8. Barton, B. E., The biological effects of interleukin 6. Med. Res. Rev. 1996. 16: 87-109.
9. Hilbert, D. M., Kopf, M., Mock, B. A., Köhler, G. and Rudikoff, S., Interleukin-6 is essential for in vivo development of B lineage neoplasms. J. Exp. Med. 1995. 182: 243-248.
10. Lattanzio, G., Libert, C., Aquilina, M., Cappelletti, M., Ciliberto, G., Musiani, P. and Poli, V., Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/mice. Am. J. Pathol. 1997. 151: 689-696.
11. Scala, G., Quinto, I., Ruocco, M. R., Arcucci, A., Mallardo, M., Caretto, P., Forni, G. and Venuta, S., Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity. J. Exp. Med. 1990. 172: 61-68.
12. Tosato, G., Jones, K., Breinig, M. K., McWilliams, H. P. and McKnight, J. L., Interleukin-6 production in posttransplant lymphoproliferative disease. J. Clin. Invest 1993. 91: 2806-2814.
13. Durandy, A., Emilie, D., Peuchmaur, M., Forveille, M., Clement, C., Wijdenes, J. and Fischer, A., Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice. J. Immunol. 1994. 152: 5361-5367.
14. Yokoi, T., Miyawaki, T., Yachie, A., Kato, K., Kasahara, Y. and Taniguchi, N., Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor. Immunology 1990. 70: 100-105.
15. Tanner, J. E. and Menezes, J., Interleukin-6 and Epstein-Barr virus induction by cyclosporine A: potential role in lymphoproliferative disease. Blood 1994. 84: 3956-3964.
16. Tanner, J. E., Alfieri, C., Chatila, T. A. and Diaz-Mitoma, F., Induction of interleukin-6 after stimulation of human B-cell CD21 by Epstein-Barr virus glycoproteins gp350 and gp220. J. Virol. 1996. 70: 570-575.
17. Klein, S. C., Jücker, M., Abts, H. and Tesch, H., IL6 and IL6 receptor expression in Burkitt's lymphoma and lymphoblastoid cell lines: Promotion of IL6 receptor expression by EBV. Hematol. Oncol. 1995. 13: 121-130.
18. Brakenhoff, J. P., De Groot, E. R., Evers, R. F., Pannekoek, H. and Aarden, L. A., Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J. Immunol. 1987. 139: 4116-4121.
19. Mosier, D. E., Adoptive transfer of human lymphoid cells to severely immunodeficient mice: models for normal human immune function, autoimmunity, lymphomagenesis, and AIDS. Adv. Immunol. 1991. 50: 303-325.
20. Custer, R. P., Bosma, G. C. and Bosma, M. J., Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms. Am. J. Pathol. 1985. 120: 464-477.
21. Duchosal, M. A., Eming, S. A., Fischer, P., Leturcq, D., Barbas, C. F., III, McConahey, P. J., Caothien, R. H., Thornton, G. B., Dixon, F. J. and Burton, D. R., Immunization of hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries. Nature 1992. 355: 258-262.
22. Veronese, M. L., Veronesi, A., D'Andrea, E., Del Mistro, A., Indraccolo, S., Mazza, M. R., Mion, M., Zamarchi, R., Menin, C., Panozzo, M., Amadori, A. and Chieco-Bianchi, L., Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation. J. Exp. Med. 1992. 176: 1763-1767.
23. Seymour, J. F. and Kurzrock, R., Interleukin-6: biologic properties and role in lymphoproliferative disorders. Cancer Treat. Res. 1996. 84: 167-206.
24. May, L. T., Neta, R., Moldawer, L. L., Kenney, J. S., Patel, K. and Sehgal, P. B., Antibodies chaperone circulating IL-6. Paradoxical effects of anti-IL-6 "neutralizing" antibodies in vivo. J. Immunol. 1993. 151: 3225-3236.
25. Martens, E., Dillen, C., Put, W., Heremans, H., Van Damme, J. and Billiau, A., Increased circulating interleukin-6 (IL-6) activity in endotoxin-challenged mice pretreated with anti-IL-6 antibody is due to IL-6 accumulated in antigen-antibody complexes. Eur. J. Immunol. 1993. 23: 2026-2029.
26. Lu, Z. Y., Brailly, H., Wijdenes, J., Bataille, R., Rossi, J. F. and Klein, B., Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-IL-6 treatments. Blood 1995. 86: 3123-3131.
27. Coccia, M. A., Weeks, S. J., Knott, C. L. and Kuus-Reichel, K., Human IL-6 enhances human lymphocyte engraftment and activation but not human antibody production in SCIDhu PBL mice. Immunobiology 1998. 198: 396-407.
28. Peters, M., Jacobs, S., Ehlers, M., Vollmer, P., Müllberg, J., Wolf, E., Brem, G., Meyer zum Büschenfelde, K.-H. and Rose-John, S., The function of the soluble interleukin 6 (IL-6) receptor in vivo: Sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J. Exp. Med. 1996. 183: 1399-1406.
29. Straus, D. J., HIV-associated lymphomas. Curr. Opin. Oncol. 1997. 9: 450-454.
30. Cesarman, E., Chadburn, A., Liu, Y. F., Migliazza, A., Dalla-Favera, R. and Knowles, D. M., BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome. Blood 1998. 92: 2294-2302.
31. Brakenhoff, J. P., de Hon, F. D., Fontaine, V., Ten Boekel, E., Schooltink, H., Rose-John, S., Heinrich, P. C., Content, J. and Aarden, L. A., Development of a human interleukin-6 receptor antagonist. J. Biol. Chem. 1994. 269: 86-93.
32. Ciapponi, L., Maione, D., Scoumanne, A., Costa, P., Hansen, M. B., Svenson, M., Bendtzen, K., Alonzi, T., Paonessa, G., Cortese, R., Ciliberto, G. and Savino, R., Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist. Nature Biotechnol. 1997. 15: 997-1001.
33. Bosma, G. C., Custer, R. P. and Bosma, M. J., A severe combined immunodeficiency mutation in the mouse. Nature 1983. 301: 527-530.
34. Boot, J. H., Geerts, M. E., De Groot, E. R. and Aarden, L. A., Murine monoclonal isotype switch variants. Detection with rat monoclonal antibodies in ELISA and isolation by sequential sublining. J. Immunol. Methods 1988. 106: 195-202.
35. Helle, M., Boeije, L. and Aarden, L. A., Functional discrimination between interleukin 6 and interleukin 1. Eur. J. Immunol. 1988. 18: 1535-1540.
36. Helle, M., Boeije, L., De Groot, E., De Vos, A. and Aarden, L., Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: Synovial fluids and sera. J. Immunol. Methods 1991. 138-47-56.
37. van der Poll, T., Levi, M., Hack, C. E., ten Cate, H., van Deventer, S. J. H., Eerenberg, A. J. M., De Groot, E. R., Jansen, J., Gallati, H., Büller, H. R., ten Cate, J. W. and Aarden, L. A., Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J. Exp. Med. 1994. 179: 1253-1259.
38. Callard, R. E., Gearing, A. J. H. and Armitage, R. J., The physico-chemical properties of B cell growth and differentiation factors and their receptors. In Callard, R. E (Ed.), Cytokines and B lymphocytes. Academic Press, London 1990, p. 11-38.
39. Duchosal, M. A., Eming, S. A., McConahey, P. J. and Dixon, F. J., Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease. Am. J. Pathol. 1992. 141: 1097-1113.